Clinical Study of Pulp Mesenchymal Stem Cells in the Treatment of Primary Mild to Moderate Knee Osteoarthritis

NCT04130100 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

BIOLOGICAL: Low Dose of Mesenchymal stem cell
BIOLOGICAL: High Dose of Mesenchymal stem cell
DRUG: Sodium Hyaluronate

Sponsor

CAR-T (Shanghai) Biotechnology Co., Ltd.